Efficacy of Gamma - tACS on Cognition and Craving in Alcohol Use Disorder:A Sham Controlled Study - nil

Central Institute of Psychiatry0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•1. Male patients diagnosed with Alcohol Dependence Syndrome as per International Classification of Disease - 11th revision - Diagnostic Criteria for Research (WHO, 2022).
•2. Male with Alcohol Dependence aged between 18 to 60 years.
•3. Severity of Alcohol Dependence Questionnaire (SADQ) in Male with Alcohol dependence greater than 16
•4. The Clinical Institute Withdrawal Assessment for Alcohol (revised version) in Male with Alcohol dependence CIWA-Ar lesser than 10.
•5. Right-handed
•6. Male with Alcohol dependence who give informed consent.
•7. Patients will be screened for cognitive deficit with Montreal Cognitive Assessment Test (MoCA). Cut off score is =25.

•1. Male with Alcohol dependence having any other co-morbid substance dependence except nicotine and caffeine.
•2. Male with Alcohol dependence having any medical illness.
•3. Male with Alcohol dependence having any other psychiatric illness, dementia, psychotic disorder,
•4. Male with Alcohol dependence who are on any psychotropic medication or any anticraving medication in 2 weeks preceding and during the study.
•5. Clinically diagnosed intellectual disability.
•6. Past history of significant head injury.
•7. Past history of epilepsy(Patients with history of alcohol withdrawal seizure will be included).
•8. HAMD Score = 8.

发起方